Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Fast Food Indonesia Tbk. (FAST) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Fast Food Indonesia Tbk.Trading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Fast Food Indonesia Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Fast Food Indonesia Tbk. diperdagangkan di Rp276 (kapitalisasi pasar 1,22 T, volume 24 jam 847,1 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 71 rb). Perbedaan utamanya: Fast Food Indonesia Tbk. jauh lebih besar — sekitar 7,3× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Fast Food Indonesia Tbk. lebih aktif diperdagangkan (847,1 rb vs 71 rb). Mana yang lebih baik tergantung tujuan investasimu.

FASTOBAT
Kapitalisasi Pasar
1,22 T167,37 M
Volume
847,1 rb71 rb
Lot
8,47 rb710
Perputaran
227,75 jt17,51 jt
Harga Rata-rata
268,86246,63
Nilai Transaksi
227,75 jt17,51 jt
Harga Ekuilibrium Indikatif
276246
Volume Ekuilibrium Indikatif
131

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

FAST
Lihat detail
OBAT
Lihat detail

Tentang Fast Food Indonesia Tbk.

PT. Fast Food Indonesia Tbk is a company founded in 1978 by the Gelael Group and the exclusive KFC franchise holder in Indonesia. The first KFC outlet opened in October 1979 at Jl. Melawai, Jakarta proved to be successful and paved the way for the opening of more additional outlets in Jakarta. The Company expanded its regional coverage to include other major cities in Indonesia and because of its success in building KFC brand image for the past 20 years of operation, KFC became the country’s dominant fast food market leader.

Selengkapnya di halaman FAST

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT